-
2026-06-24
GenSci's Triptorelin Acetate for Injection (II) Secures NMPA Approval for Central Precocious PubertyLearn More
-
2026-06-04
GenSci: Two Innovations Granted IND Clearance by FDALearn More
-
2026-05-28
Dr. Lei Jin of GenSci Shines at J.P. Morgan Global China Summit, Sharing Insights on Innovation and GlobalizationLearn More
-
2026-05-19
GenSci's Innovative IL-1α/β Bispecific Antibody Receives First FDA Clinical ApprovalLearn More
-
2026-05-15
GenSciP166 Selected as Late-Breaking Abstract at SID 2026Learn More
-
2024-08-29
GenSci098 Injection Obtains Implied License For Clinical Trials of FDALearn More
-
2024-08-21
Jintrolong? New Dosage Form of Long-acting Somatropin Injection ApprovedLearn More
-
2024-08-06
Clinical Trial Commencement of GenSci098 Injection ApprovedPreclinical data indicate GenSci098 has the potential to become a new treatment for Thyroid Eye Disease
Learn More
-
2024-07-26
Zhejiang University – GenSci Joint Research Center of Children’s Health establishedLearn More
-
2024-07-23
NMPA: New Drug Application of Recombinant Human Follicle-Stimulating Hormone - CTP Fusion Protein Injection AcceptedThis product will potentially enhance convenience and patient compliance
Learn More
-
2024-07-09
R&D Innovation Accelerator: Shanghai Children's Hospital and GenSci Ink Strategic Cooperation AgreementTwo Sides will Collaboratively Set Up a R&D Center
Learn More